Scientists ID mechanisms that could drive neurodegeneration in MS

How weathering hurricanes is like living with multiple sclerosis

As a native Floridian, I’ve been through my fair share of hurricanes. Because they’re so familiar, I’m probably a bit too indifferent to them. But in many ways, hurricanes parallel my life with relapsing-remitting multiple sclerosis (RRMS); each involves preparation, weathering of the storm, and adjusting to the aftermath.

EC slaps Teva with €463M fine over misuse of Copaxone patents

The European Commission (EC) fined Teva Pharmaceuticals €462.6 million — more that $502 million — after an investigation it launched found the company illegally tried to stop competitor versions of Copaxone (glatiramer acetate injection), its blockbuster drug for multiple sclerosis (MS), from entering markets. Several patents…

After a long month, I’m appreciating life without MS worries, for now

Being diagnosed with relapsing-remitting multiple sclerosis doesn’t necessarily mean that other health complications or conditions won’t arise. According to an article published in the journal Multiple Sclerosis and Related Disorders, multiple sclerosis (MS) patients have significantly higher rates of comorbidity and morbidity than people who don’t have…

Brain blood vessels key to new MS treatments, researchers argue

Developing a more comprehensive understanding of the interactions between the brain, blood vessels, and the immune system holds great promise for unlocking new ways to treat neurological diseases like multiple sclerosis (MS), a team of researchers argued in a new commentary paper. “Interactions between the brain, blood vessels, and…

DMTs have slowed RRMS disability progression rate: Analysis

The rate of disability progression among people with relapsing-remitting multiple sclerosis (RRMS) has slowed over the years due to advances in disease-modifying therapies (DMTs), according to a long-term analysis. Patients diagnosed in recent decades have experienced fewer progression events associated with relapses, called relapse-associated worsening (RAW), and also…

Researchers find sulfuretin molecule may promote myelin repair

Researchers at the Oregon Health & Science University have discovered a plant-derived small molecule that can promote the growth of cells that produce myelin, the protective coating around nerve fibers that’s damaged in multiple sclerosis (MS). The naturally occurring molecule, sulfuretin, blocks the activity of an enzyme that…

Cholesterol medications might be able to be repurposed for MS: Study

Increased production of cholesterol by stem cells in the brain contributes to neurological damage in multiple sclerosis (MS), according to a new study conducted in lab-grown cells. Findings suggest cholesterol-lowering medications can reverse this damage, implying such treatments might be able to be repurposed for MS. “Cholesterol metabolism has…

Ancient viral genes in human DNA linked to MS in study

Abnormal activity of ancient viral genes may play a role in the development of multiple sclerosis (MS) and other neurological disorders, a study found. “Future functional studies are essential to elucidate the molecular and cellular mechanisms underlying their involvement in these conditions,” the researchers wrote. The study, “…

Communication in relationships is crucial when living with MS

After I was diagnosed with relapsing-remitting multiple sclerosis (MS) in 2016, I thought I’d never find a partner who understood the complexities and nuances of my condition. For years, I wondered, “If I can barely comprehend the knowns and unknowns of living with MS, how could anyone else?” Oh…

Genetic modifications to myelin-making cells boost myelin repair

Transplanting genetically engineered oligodendrocyte progenitor cells (OPCs), which give rise to mature myelin-making cells, significantly boosted myelin repair in mice with multiple sclerosis (MS)-like chronic brain lesions. The cells were engineered to ignore chemical signals that would normally inhibit OPCs being recruited into lesions and then restore…